IN THE HIGH COURT FOR THE STATE OF TELANGANA AT HYDERABAD
Nagesh Bheemapaka, J
Reddy’s Laboratories Limited – Appellant
Versus
Competition Commission of India – Respondent
WRIT PETITION No. 25689 OF 2024
| Table of Content |
|---|
| 1. nature of petitioner's pharmaceutical business and procedural history of the competition commission investigation. (Para 1) |
| 2. respondents' claims regarding the statutory authority to investigate and procedural necessity of financial disclosures. (Para 2) |
| 3. interim procedural orders remain non-adjudicatory and outside writ jurisdiction. (Para 4 , 5 , 6 , 7 , 8) |
| 4. distinction and inapplicability of precedents to premature judicial intervention. (Para 9 , 10) |
| 5. merits of coercive conduct and prior exonerations are for the commission to decide. (Para 11 , 12 , 13 , 14 , 15) |
| 6. procedural irregularities, delay, and composition defects do not invalidate ongoing statutory inquiries. (Para 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28) |
| 7. dismissal of petition with liberty to raise merits before the commission. (Para 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36) |
O R D E R:
Petitioner is a renowned pharmaceutical company engaged in the business of providing Active Pharmaceutical Ingredients (API), generics, branded generics, biosimilars and over-the-counter pharmaceutical products across the world, and has earned global recognition for providing access to affordable and innovative medicines while investing in drug discovery, clinically differentiated assets and digital healthcare.
1.1. It is stated, petitioner Company, during various periods between the early 2000 and 2020, was a member of the Indian Drug Manufacturers' Association (IDMA), the country's largest pharmaceutical industry association for bulk drugs with over 1000 members, and is also a member of the Indian Pharmaceutical Alliance (IPA), an organization of research-based pharmaceutical companies in India, and like other pharmaceutical manufacturers, Petitioner Company was compelled to abide by the rules and regulations prescribed by such associations, including IDMA and IPA.
1.2. On 27.01.1997, a Memorandum of Understanding was executed between IDMA, Organization of Pharmaceutical Producers of India (OPPI) and All India Organization of Chemists and Druggists (AIOCD) governing practices relating to sale and distribution of pharmaceutical products including expiry norms, distribution norms, product information service system, supply of products through authorized stockists and issues relating to spurious drugs, and that the said Memorandum was entered into at a time when the Competition Act, 2002 (for short, ‘the Act’) was not in force in India, and that over the years and until the notification of Sections 3 and 4 of the Act on 20.05.2009, the parties had moved away from the practices prevalent in the 1997-era.
1.3. On 19.01.2012, Respondent No.6, namely Mr. Kailash Gupta, President of All India Chemists and Distributors Federation, filed information under Section 19(1)(a) of the Act alleging contravention of Sections 3 and 4 of the Act by AIOCD and various pharmaceutical manufacturers including Petitioner Company, and such allegations, as per the Petitioner, arise out of commercial rivalry between downstream trade associations, and that the Informant had primarily alleged breach of the Act by AIOCD.
1.4. It is contended, on 07.02.2012, the Commission passed an order under Section 26(1) of the Act forming only a prima facie opinion and directing investigation, wherein it relied upon the said Memorandum and observed that there existed a prima facie case of anti-competitive conduct, inter alia on the grounds that the Memorandum mandated obtaining of LOC/NOC from AIOCD prior to appointment of stockists, that AIOCD charged Rs.2000/- as Product Information Services and that the practices indicated existence of a cartel, though such findings were only at a preliminary stage and were yet to be established through cogent evidence relatable to the Act. Petitioner Company was wrongly impleaded as an opposite party by the said order dated 07.02.2012 despite being a mere manufacturing company and despite the Commission itself observing that manufacturers were v
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.